Cadre Holdings, Inc.

CDRE ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $11.4M $2.0M $11.7M $10.9M $12.2M $9.2M $13.0M $3.7M
Depreciation & Amortization $6.2M $5.7M $4.7M $5.4M $4.7M $3.9M $4.1M $3.8M
Depreciation — — — — — — — —
Amortization $3.2M $2.9M $2.1M $2.6M $2.4M $2.1M $2.2M $2.0M
Stock-Based Compensation $3.0M $1.9M $5.4M $2.4M $2.4M $2.0M $2.1M $2.1M
Net Cash from Operating Activities $22.1M $22.5M $21.3M $22.5M $2.6M $17.4M $23.7M $-5.2M
Investing Activities
Capital Expenditures $3.5M $2.7M $3.3M $849.0K $1.4M $1.3M $1.3M $1.0M
Business Acquisitions $10.3M $153.6M — — — — $0 $0
Net Cash from Investing Activities $-13.8M $-156.2M $-3.2M $-849.0K $-91.0M $-1.3M $-1.3M $-991.0K
Financing Activities
Dividends Paid $4.3M $4.3M $3.9M $3.9M $3.9M $3.9M $3.6M $3.6M
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $4.4M $52.9M $-43.8M $-7.6M $90.8M $-7.8M $9.8M $-7.1M
Net Change in Cash $14.0M $-81.7M $-25.5M $13.4M $4.0M $8.5M $31.9M $-12.9M
Free Cash Flow $18.7M $19.8M $18.0M $21.6M $1.2M $16.1M $22.4M $-6.2M
← Newer Page 1 of 3 Older →